iNPH-the mystery resolving.
Ville LeinonenTeemu KuulasmaaMikko HiltunenPublished in: EMBO molecular medicine (2021)
Idiopathic normal pressure hydrocephalus (iNPH) is characterized clinically by degradation of gait, cognition, and urinary continence. INPH is progressive (Andrén et al, 2014), still probably underdiagnosed (Williams et al, 2019) but potentially treatable by CSF diversion (Kazui et al, 2015). Familial aggregation is a strong indicator of genetic regulation in the disease process iNPH (Fig 1). Enlargement of brain ventricles is associated with failed cerebrospinal (CSF) homeostasis by so far mostly unknown mechanisms. A mutation of the cilia gene CFAP43 in iNPH family, confirmed by a knocked-out mouse model (Morimoto et al, 2019), allelic variation of NME8 (Huovinen et al, 2017), a segmental copy number loss in SFMBT1 in selected iNPH patients (Sato et al, 2016), and current results by Yang et al (2021) indicate that cilia dysfunction is one of the key mechanisms behind iNPH.
Keyphrases
- peritoneal dialysis
- end stage renal disease
- copy number
- mitochondrial dna
- genome wide
- mouse model
- robot assisted
- dna methylation
- cerebrospinal fluid
- multiple sclerosis
- chronic kidney disease
- oxidative stress
- ejection fraction
- early onset
- newly diagnosed
- urinary incontinence
- mild cognitive impairment
- brain injury
- cerebral palsy
- patient reported outcomes
- cerebral ischemia